1.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: STX0206, NCT00724503
|
|
2.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Sir-Spheres1, NCT00199173
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CTCT 06-11, NCT00493883
|
|
4.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NMRC - AHCC05, NCT00712790
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: PCI-IRB-0611014, PCI-IRB-000656, PCI-IRB-000871, NCI-V02-1701, NCT00039078
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: CCCGHS-SIRT-SERT, NCT00436267
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: STX 0106, NCT00503867
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NU-1365-001, NU 1365-001, NCT00530010
|
|
9.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NU-1365-002, NU 1365-002, NCT00532740
|
|
10.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: G040148, NCT00511862
|
|
11.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CHNMC-06057, 06057, NCT00589030
|
|
12.
|
Phase: Phase I Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: NU-08I5, NU 08I5, STU00007062, NCT00858429
|
|
13.
|
Phase: No phase specified Type: Natural history/Epidemiology Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NU-07Q1, NU 07Q1, NU-IRB-STU00002799, NCT00739167
|
|
14.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: TheraSphere - 421.03, NCT00683631
|
|
15.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-029 TheraSphere®, NCT00877136
|